Devra M. Barter

1.2k total citations
10 papers, 715 citations indexed

About

Devra M. Barter is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Devra M. Barter has authored 10 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Devra M. Barter's work include Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). Devra M. Barter is often cited by papers focused on Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). Devra M. Barter collaborates with scholars based in United States, India and South Africa. Devra M. Barter's co-authors include Ramanan Laxminarayan, Sumanth Gandra, Megan Murray, Stephen Agboola, Till Bärnighausen, Benjamin P. Linas, Jared A. Leff, Bruce R. Schackman, Joshua A. Salomon and Milton C. Weinstein and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Devra M. Barter

10 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devra M. Barter United States 10 366 260 229 153 74 10 715
Sulaiman Lakoh Sierra Leone 14 260 0.7× 280 1.1× 67 0.3× 82 0.5× 55 0.7× 77 539
Mucheye Gizachew Ethiopia 15 448 1.2× 305 1.2× 31 0.1× 113 0.7× 110 1.5× 33 770
Carlos Roberto Veiga Kiffer Brazil 17 337 0.9× 165 0.6× 94 0.4× 247 1.6× 500 6.8× 63 977
A Muruganathan India 10 181 0.5× 71 0.3× 62 0.3× 78 0.5× 64 0.9× 32 479
Benjamin A. Kupronis United States 8 712 1.9× 359 1.4× 427 1.9× 28 0.2× 30 0.4× 12 1.1k
Baba Maiyaki Musa Nigeria 13 350 1.0× 225 0.9× 152 0.7× 7 0.0× 15 0.2× 57 831
Stephanie Kohl Italy 9 114 0.3× 30 0.1× 62 0.3× 42 0.3× 26 0.4× 39 395
Christine U. Oramasionwu United States 15 295 0.8× 264 1.0× 64 0.3× 26 0.2× 12 0.2× 36 776
Lakhbir Singh Chauhan India 8 469 1.3× 743 2.9× 38 0.2× 11 0.1× 11 0.1× 11 942
Olukemi Adekanmbi Nigeria 9 111 0.3× 105 0.4× 27 0.1× 80 0.5× 37 0.5× 29 254

Countries citing papers authored by Devra M. Barter

Since Specialization
Citations

This map shows the geographic impact of Devra M. Barter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devra M. Barter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devra M. Barter more than expected).

Fields of papers citing papers by Devra M. Barter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devra M. Barter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devra M. Barter. The network helps show where Devra M. Barter may publish in the future.

Co-authorship network of co-authors of Devra M. Barter

This figure shows the co-authorship network connecting the top 25 collaborators of Devra M. Barter. A scholar is included among the top collaborators of Devra M. Barter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devra M. Barter. Devra M. Barter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Seagle, Emma E., Brendan R. Jackson, Shawn R. Lockhart, et al.. (2021). The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic. Clinical Infectious Diseases. 74(5). 802–811. 98 indexed citations
2.
Barter, Devra M., Helen Johnston, Sabrina Williams, et al.. (2019). Candida Bloodstream Infections Among Persons Who Inject Drugs — Denver Metropolitan Area, Colorado, 2017–2018. MMWR Morbidity and Mortality Weekly Report. 68(12). 285–288. 14 indexed citations
3.
Nandi, Arindam, Devra M. Barter, Shankar Prinja, & T. Jacob John. (2016). The Estimated Health and Economic Benefits of Three Decades of Polio Elimination Efforts in India.. PubMed. 53 Suppl 1. S7–S13. 9 indexed citations
4.
Linas, Benjamin P., Devra M. Barter, Jake R. Morgan, et al.. (2015). The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection. Annals of Internal Medicine. 162(9). 619–629. 82 indexed citations
5.
Linas, Benjamin P., Haihong Hu, Devra M. Barter, & Michael A. Horberg. (2014). Hepatitis C Screening Trends in a Large Integrated Health System. The American Journal of Medicine. 127(5). 398–405. 30 indexed citations
6.
Linas, Benjamin P., Devra M. Barter, Jared A. Leff, et al.. (2014). The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes. PLoS ONE. 9(5). e97317–e97317. 103 indexed citations
7.
Gandra, Sumanth, Devra M. Barter, & Ramanan Laxminarayan. (2014). Economic burden of antibiotic resistance: how much do we really know?. Clinical Microbiology and Infection. 20(10). 973–980. 185 indexed citations
8.
Schackman, Bruce R., Jared A. Leff, Devra M. Barter, et al.. (2014). Cost‐effectiveness of rapid hepatitisCvirus (HCV) testing and simultaneous rapidHCVandHIVtesting in substance abuse treatment programs. Addiction. 110(1). 129–143. 34 indexed citations
9.
Linas, Benjamin P., Devra M. Barter, Jared A. Leff, et al.. (2013). The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS. 28(3). 365–376. 18 indexed citations
10.
Barter, Devra M., Stephen Agboola, Megan Murray, & Till Bärnighausen. (2012). Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa – a systematic review. BMC Public Health. 12(1). 980–980. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sulaiman Lakoh Breakdown of academic impact, for papers by Mucheye Gizachew Breakdown of academic impact, for papers by Carlos Roberto Veiga Kiffer Breakdown of academic impact, for papers by A Muruganathan Breakdown of academic impact, for papers by Benjamin A. Kupronis Breakdown of academic impact, for papers by Baba Maiyaki Musa Breakdown of academic impact, for papers by Stephanie Kohl Breakdown of academic impact, for papers by Christine U. Oramasionwu Breakdown of academic impact, for papers by Lakhbir Singh Chauhan Breakdown of academic impact, for papers by Olukemi Adekanmbi
Rankless by CCL
2026